Valuation EBOS Group Limited OTC Markets

Stocks

Market Closed - OTC Markets 23:01:31 21/10/2026 +03			5-day change	1st Jan Change
23.00 ^USD	+16.99%		+16.99%	-34.34%

10-21	EBOS Group Limited - Shareholder/Analyst Call
09-09	EBOS Group Declares Strike Price for Shares under Dividend Reinvestment Plan	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	6,673	6,481	5,707	7,241	3,538	3,465	-	-
Change	-	-2.88%	-11.94%	26.88%	-51.14%	-2.07%	-	-
Enterprise Value (EV) ¹	7,534	7,248	6,726	8,159	4,573	4,478	4,439	4,397
Change	-	-3.8%	-7.2%	21.31%	-43.96%	-2.08%	-0.86%	-0.94%
P/E	27.6x	23.6x	19x	29.3x	15.6x	14.8x	12.9x	12.1x
PBR	2.95x	2.65x	2.32x	2.64x	1.29x	1.25x	1.25x	1.24x
PEG	-	1.9x	2.38x	-1.4x	-1.61x	5.19x	0.8x	1.89x
Capitalization / Revenue	0.56x	0.49x	0.39x	0.53x	0.26x	0.25x	0.24x	0.23x
EV / Revenue	0.63x	0.55x	0.46x	0.6x	0.34x	0.32x	0.3x	0.29x
EV / EBITDA	15.5x	11.5x	9.82x	12.6x	7.45x	6.91x	6.39x	5.98x
EV / EBIT	19.1x	13.9x	11.7x	15.8x	9.82x	9.17x	8.36x	7.75x
EV / FCF	42.4x	22.9x	26.7x	27x	22.6x	27.5x	15.3x	13.8x
FCF Yield	2.36%	4.37%	3.74%	3.71%	4.43%	3.63%	6.56%	7.24%
Dividend per Share ²	1.071	1.087	1.08	1.067	0.986	0.9423	1.038	1.104
Rate of return	3.04%	3.21%	3.66%	2.99%	5.77%	5.63%	6.2%	6.59%
EPS ²	1.275	1.436	1.55	1.216	1.098	1.129	1.302	1.386
Distribution rate	84%	75.7%	69.6%	87.8%	89.8%	83.4%	79.7%	79.7%
Net sales ¹	11,952	13,223	14,473	13,594	13,487	14,025	14,640	15,256
EBITDA ¹	486.3	628.9	685.1	648.3	614	647.7	695	735
EBIT ¹	395.3	523.2	572.5	515.3	465.8	488.4	531	567.6
Net income ¹	225.6	273.8	297.9	238.3	225	227.6	263.3	287.6
Net Debt ¹	860.5	766.6	1,019	918.3	1,034	1,013	974.4	932.6
Reference price ²	35.24	33.83	29.53	35.63	17.10	16.74	16.74	16.74
Nbr of stocks (in thousands)	189,383	191,604	193,243	203,230	206,949	206,971	-	-
Announcement Date	8/23/22 A	8/22/23 A	8/20/24 A	8/26/25 A	8/18/26 A	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.50x	7.04x	18.69x	2.12%	444.85B
Weighted average by Cap.	35.23x	8.29x	20.39x	1.8%